Dr. Fahad Attar, Consultant Orthopaedic Surgeon and CEOInitial management of this joint ailment often involves physical therapy and pain medications, whereas the progression to advanced stages may necessitate joint replacement surgeries. However, a notable treatment chasm exists for those in the moderate phase of osteoarthritis—individuals who find conservative treatments insufficient yet are not in immediate need of surgical intervention.
This gap is where Regenesiss seeks to make a difference.
Specialising in orthobiological therapies, the company aims to tap into the body’s natural healing abilities. This approach focuses on stimulating tissue repair, cartilage rebuilding, reducing inflammation and enhancing joint function, offering an alternative to the risks and recovery associated with invasive surgeries.
What sets Regenesiss apart is its holistic patient care strategy. The clinic has a multidisciplinary team of highly skilled professionals, including orthopaedic surgeons, physical therapists, nutritionists, pharmacologists, pain consultants and rheumatologists. They work in unison to offer a comprehensive suite of musculoskeletal consultations and services, ensuring that each patient receives well-rounded care tailored to their needs.
Dr. Fahad Attar, consultant orthopaedic surgeon and CEO of Regenesiss, highlights the critical role of patient education in the healing journey. He states, “Education is a cornerstone of our healing approach. We extend learning opportunities to both professionals and patients through seminars and Q&A sessions. This open forum encourages discussion and ensures patients are well-informed about their treatment options.”
Regenesiss adopts a straightforward yet effective approach—conducting a comprehensive assessment of each patient’s condition to devise tailored treatment plans, moving away from the generic one-size-fits-all methodology. This process begins with an in-depth patient history and a thorough diagnostic evaluation to uncover any underlying issues. What follows is a bespoke treatment process that consists of the right mix from a diverse array of advanced biological treatment options. Among these are treatments like platelet-rich plasma (PRP) and platelet-derived growth factor (PDGF) injections, which leverage the body’s own regenerative capabilities to encourage tissue healing and repair.
The therapeutic approach of Regenesiss further proves to be a boon for people suffering from sports injuries. By leveraging orthobiologic therapies, Regenesiss not only enhances the quality of life and athletic performance of these individuals but ensures shorter recovery periods, allowing them to return to their active lifestyles more swiftly.
A compelling testament to the efficacy of orthobiologics is the story of a professional hockey player who represented her country on the international stage, including the Olympics. She approached the clinic with debilitating hip pain that hindered her ability to train and compete. Diagnostic procedures uncovered a cartilage tear in her hip, which was addressed with Platelet-Rich Plasma (PRP) injection therapies and supplemented by nutritional guidance. The response to this tailored treatment was profound; within weeks, she made a comeback, competing again at the highest levels. Further supported by follow-up PRP injections, she achieved full recovery, restoring her to elite functionality in playing for the UK.
We empower individuals to reclaim their vitality and mobility, offering a profound lifeline to those grappling with the debilitating challenges of musculoskeletal disorders, sports injuries and osteoarthritis
Regenesiss’ dedication to providing the best possible care for its patients has garnered widespread recognition. A highlight of this acclaim came when Dr. Attar was bestowed with the esteemed ‘Orthopaedic Surgeon of the Year Global 2023’ award by the FORTTUNA Global Excellence Awards 2023 in Dubai, a clear acknowledgement of the clinic’s exceptional commitment to patient care and its contributions to the advancement of regenerative orthopaedics.
With a focus on accessibility, Regenesiss operates its flagship clinic in Manchester, a satellite clinic in London and facilities in Scotland and the Midlands. This extensive network enables the company to cater to a wide geographical area. Beyond its physical locations, Regenesiss embraces technology through virtual consultations, allowing patients across the UK to easily access its pioneering regenerative therapies.
Eyeing a future beyond national borders, Regenesiss is planning to expand its operations internationally, with new facilities slated for Dubai, Saudi Arabia (KSA), Nigeria, Turkey and Egypt within the next three years. This strategic expansion is designed to enhance the accessibility of the clinic’s groundbreaking treatments on a global scale, aiming to make a significant impact in transforming orthopaedic wellness worldwide.


